In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding. Tannu M, Newby LK. Ann Intern Med 2023;176:JC123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tannu M, Newby LK. In CAD, P2Y12 inhibitor vs. aspirin monotherapy reduces a composite CV outcome without increasing major bleeding. Ann Intern Med 2023;176:JC123.
PMID: 37931259